Syndax Pharmaceuticals

SNDX NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $11.21-$25.34
Market Cap $1.6B
Shares Short 10M

Financials

See more
Revenue (12 Mos) $126.5M
Revenue Growth (YoY) 33,297.4%
Gross Profit (12 Mos) $139.7M
Diluted EPS -$3.24

About

CEO Mr. Michael A. Metzger M.B.A.
CFO Mr. Keith Alan Goldan CPA
Address 35 Gatehouse Drive, Waltham, MA, United States, 02451
Sector Healthcare
Industry Biotechnology
Full-Time Employees 184